91 related articles for article (PubMed ID: 6447539)
1. Skin rashes associated with the administration of the 2-nitroimidazole, misonidazole.
Saunders MI; Dische S; Kogelnik HD; Sealy R; Lenox-Smith I
Cancer Treat Rep; 1980; 64(2-3):263-8. PubMed ID: 6447539
[TBL] [Abstract][Full Text] [Related]
2. New side effect of the hypoxic cell sensitizer, misonidazole.
Partington J; Koziol D; Chapman D; Rabin H; Urtasun RC
Cancer Treat Rep; 1979 Jan; 63(1):123-5. PubMed ID: 217536
[TBL] [Abstract][Full Text] [Related]
3. Misonidazole Neuropathy: a clinical, electrophysiological, and histological study.
Melgaard B; Hansen HS; Kamieniecka Z; Paulson OB; Pedersen AG; Tang X; Trojaborg W
Ann Neurol; 1982 Jul; 12(1):10-7. PubMed ID: 7114817
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with misonidazole: high dose fractions versus daily low doses.
Kogelnik HD
Cancer Clin Trials; 1980; 3(2):179-86. PubMed ID: 6253098
[TBL] [Abstract][Full Text] [Related]
5. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
Walker MD; Strike TA
Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094
[TBL] [Abstract][Full Text] [Related]
6. [Clinical experiences with the radiation-sensitizing agent misonidazole].
Kogelnik HD; Szepesi T; Kärcher KH; Seitz W
Strahlentherapie Sonderb; 1978; 75():115-9. PubMed ID: 162327
[No Abstract] [Full Text] [Related]
7. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
Asakawa H; Watarai J; Hoshino T
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1225-30. PubMed ID: 6732250
[TBL] [Abstract][Full Text] [Related]
8. [Clinical experience with daily doses of misonidazole (author's transl)].
Kogelnik HD; Reinartz G; Szepesi T; Seitz W; Wurst F; Mamoli B; Wessely P; Stark H
Strahlentherapie; 1980 Nov; 156(11):758-64. PubMed ID: 7434385
[TBL] [Abstract][Full Text] [Related]
9. Rashes associated with intravenous administration of ampicillin.
Scioli C; Esposito S; Lettieri G; Galante D
Boll Ist Sieroter Milan; 1983 Jul; 62(3):287-91. PubMed ID: 6227325
[TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum of drug rashes due to antiepileptics.
Sharma VK; Vatve M; Sawhney IM; Kumar B
J Assoc Physicians India; 1998 Jul; 46(7):595-7. PubMed ID: 12152838
[TBL] [Abstract][Full Text] [Related]
11. The response of human tumour metastases to radiation and misonidazole.
Dawen PJ; Peckham MJ; Steel GG
Br J Cancer Suppl; 1978 Jun; 3():290-6. PubMed ID: 277247
[TBL] [Abstract][Full Text] [Related]
12. Misonidazole neuropathy.
Paulson OB; Melgaard B; Hansen HS; Kamieniecka Z; Køhler O; Hansen JM; Pedersen AG; Tang X; Trojaborg W
Acta Neurol Scand Suppl; 1984; 100():133-6. PubMed ID: 6091392
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic transformations in vitro produced by misonidazole.
Miller RC; Hall EJ
Cancer Clin Trials; 1980; 3(1):85-90. PubMed ID: 7389040
[TBL] [Abstract][Full Text] [Related]
14. Effect of misonidazole therapy on human granulopoietic stem cells.
Allalunis MJ; Turner AR; Partington JP; Urtasun RC
Cancer Treat Rep; 1980; 64(10-11):1097-102. PubMed ID: 7459895
[TBL] [Abstract][Full Text] [Related]
15. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-induced DRESS syndrome in a female patient.
Vauthey L; Uçkay I; Abrassart S; Bernard L; Assal M; Ferry T; Djordjevic M; Roussos C; Vaudaux P
Pharmacology; 2008; 82(2):138-41. PubMed ID: 18607115
[TBL] [Abstract][Full Text] [Related]
17. Nature and incidence of misonidazole-produced ototoxicity.
Waltzman SB; Cooper JS
Arch Otolaryngol; 1981 Jan; 107(1):52-4. PubMed ID: 7469881
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentration of misonidazole and peripheral neuropathy.
Marten TR
Am J Clin Oncol; 1982 Apr; 5(2):239-40. PubMed ID: 6283876
[No Abstract] [Full Text] [Related]
19. Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
Coleman CN; Friedman MK; Jacobs C; Halsey J; Ignoffo R; Leibel S; Hirst VK; Gribble M; Carter SK; Phillips TL
Cancer Res; 1983 Oct; 43(10):5022-5. PubMed ID: 6883348
[TBL] [Abstract][Full Text] [Related]
20. I.V. misonidazole (NSC 261037). Report of initial clinical experience.
Schwade JG; Strong JM; Gangji D
Cancer Clin Trials; 1981; 4(1):33-9. PubMed ID: 7214660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
